Dr. Chanu Rhee is an Associate Professor of Population Medicine at Harvard Medical School and an infectious disease and critical care physician and Associate Hospital Epidemiologist at Brigham and Women’s Hospital. He graduated summa cum laude from Georgetown University School of Medicine and completed his internal medicine residency, chief residency, and critical care medicine fellowship at Stanford University Hospital prior to his infectious disease fellowship in the combined Massachusetts General Hospital / Brigham and Women’s Hospital program and MPH degree at Harvard T.H. Chan School of Public Health.
Dr. Rhee is an internationally recognized expert in the epidemiology, surveillance, diagnosis, prevention, and management of sepsis. His clinical and research interests also include infection control and healthcare epidemiology, antibiotic resistance and stewardship, infections in critically ill and immunocompromised patients, and COVID-19. He has published numerous influential studies that have leveraged local and national electronic health record datasets to inform clinical care and healthcare policy related to these topics. His work led to the development of the U.S. Centers for Disease Control and Prevention’s sepsis surveillance strategy that is being used to better track sepsis incidence and outcomes, provide new insights into risk factors and treatment strategies, and drive further innovations in care. He has also been a leader in sepsis quality improvement efforts within the Mass General Brigham Healthcare System and has participated in several national committees focusing on improving sepsis care and outcomes, including initiatives sponsored by the Infectious Diseases Society of America, the American College of Emergency Physicians, the Centers for Disease Control and Prevention, and the Centers for Medicare & Medicaid Services.
Dr. Rhee attends clinically on the transplant / oncology infectious disease service and in the Medical ICU at Brigham and Women’s Hospital. He is an associate editor for Clinical Infectious Diseases, a member of the editorial boards for Critical Care Medicine and Critical Care Explorations, and a recipient of grant funding from the National Institutes of Health, Centers for Disease Control and Prevention, and Agency for Healthcare Research and Quality.